Ainos Inc Total Liabilities

Latest as of June 2026: $16.28 Million USD

Ainos Inc total liabilities. Based on the latest financial reports, Ainos Inc (AIMD) has total liabilities worth $16.28 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Ainos Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Ainos Inc (1995–2025)

Total liabilities of Ainos Inc from 1995 to 2025. This chart illustrates how Ainos Inc's total liabilities have evolved over time, based on quarterly financial data.

Ainos Inc Competitors by Total Liabilities

The table below lists competitors of Ainos Inc ranked by their total liabilities.

Company Country Total Liabilities
My Rewards International Ltd
AU:MRI
Australia AU$7.76 Million
QX Resources Ltd
AU:QXR
Australia AU$378.86K
Zimtu Capital Corp
V:ZC
Canada CA$1.10 Million
Dynasty Gold Corp
V:DYG
Canada CA$542.41K
GEOTRANS S.A. ZY -10
F:5Z4
Germany €5.76 Million
CAQ Holdings Ltd
AU:CAQ
Australia AU$8.14 Million
Avricore Health Inc
V:AVCR
Canada CA$389.17K

Liability Composition Analysis (1995–2025)

This chart breaks down Ainos Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see AIMD total asset value.

Liquidity & Leverage Metrics

Ainos Inc Total Liabilities Ratios Explained

Ainos Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 0.13 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 4.96 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.83 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ainos Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ainos Inc (1995–2025)

The table below shows the annual total liabilities of Ainos Inc from 1995 to 2025.

Year Total Liabilities Change
2025-12-31 $13.31 Million +0.03%
2024-12-31 $13.30 Million +79.92%
2023-12-31 $7.39 Million +198.03%
2022-12-31 $2.48 Million -91.90%
2021-12-31 $30.63 Million +2687.72%
2020-12-31 $1.10 Million +45.83%
2019-12-31 $753.31K +2.68%
2018-12-31 $733.62K -59.76%
2017-12-31 $1.82 Million +43.26%
2016-12-31 $1.27 Million +115.97%
2015-12-31 $589.24K +30.28%
2014-12-31 $452.28K -90.85%
2013-12-31 $4.94 Million +16.55%
2012-12-31 $4.24 Million +0.57%
2011-12-31 $4.22 Million +16.23%
2010-12-31 $3.63 Million -27.21%
2009-12-31 $4.99 Million +58.90%
2008-12-31 $3.14 Million +12.84%
2007-12-31 $2.78 Million +0.98%
2006-12-31 $2.75 Million +4.10%
2005-12-31 $2.65 Million -6.62%
2004-12-31 $2.83 Million +5.08%
2003-12-31 $2.70 Million -18.63%
2002-12-31 $3.31 Million +2.88%
2001-12-31 $3.22 Million +5.32%
2000-12-31 $3.06 Million +89.98%
1999-12-31 $1.61 Million -44.83%
1998-12-31 $2.92 Million +3.69%
1997-12-31 $2.81 Million +1.34%
1996-12-31 $2.78 Million -13.22%
1995-12-31 $3.20 Million --

About Ainos Inc

NASDAQ:AIMD USA Scientific & Technical Instruments
Market Cap
$4.58 Million
Market Cap Rank
#28685 Global
#5901 in USA
Share Price
$0.62
Change (1 day)
+0.00%
52-Week Range
$0.62 - $3.26
All Time High
$156.75
About

Ainos, Inc., a dual-platform company, focusing artificial intelligence"based smelltech technologies and immune therapeutics. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data. The company provides its platforms for semiconductor manufacturing, robotics, and smart manufacturing indus… Read more